Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / G•••••• O•••••••• I•••

G•••••• O•••••••• I•••

Stage unknownNewton, MAPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Apr 15, 2026
    Form D equity offering · $4.8M (form d sold) · 37 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “G•••••• O•••••••• I••• filed Form D: $4,805,299 sold of $4,805,299, Pharmaceuticals
  2. Jun 25, 2019
    Form D equity offering · $7.2M (form d sold) · 35 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “G•••••• O•••••••• I••• filed Form D/A: $7,203,721 sold of $11,250,000, Pharmaceuticals
Investors on record
0 edges
No named investor yet.
People
7 officers, 3 directors
Timeline
3
  1. Apr 23, 2026
    G•••••• O•••••••• I••• filed Form D: $4,805,299 sold of $4,805,299, Pharmaceuticals
  2. Jul 2, 2025
    G•••••• O•••••••• I••• filed Form D/A: $10,879,308 sold of $17,325,000, Pharmaceuticals
  3. Jul 2, 2024
    G•••••• O•••••••• I••• filed Form D/A: $7,203,721 sold of $11,250,000, Pharmaceuticals
Evidence
43 observations
Every observation on this company